Cardiac repair with thymosin β4 and cardiac reprogramming factors

Deepak Srivastava, Masaki Ieda, Jidong Fu, Li Qian

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Heart disease is a leading cause of death in newborns and in adults. We previously reported that the G-actin-sequestering peptide thymosin β4 promotes myocardial survival in hypoxia and promotes neoangiogenesis, resulting in cardiac repair after injury. More recently, we showed that reprogramming of cardiac fibroblasts to cardiomyocyte-like cells in vivo after coronary artery ligation using three cardiac transcription factors (Gata4/Mef2c/Tbx5) offers an alternative approach to regenerate heart muscle. We have combined the delivery of thymosin β4 and the cardiac reprogramming factors to further enhance the degree of cardiac repair and improvement in cardiac function after myocardial infarction. These findings suggest that thymosin β4 and cardiac reprogramming technology may synergistically limit damage to the heart and promote cardiac regeneration through the stimulation of endogenous cells within the heart.

Original languageEnglish
Pages (from-to)66-72
Number of pages7
JournalAnnals of the New York Academy of Sciences
Volume1270
Issue number1
DOIs
Publication statusPublished - 2012 Oct

Fingerprint

Thymosin
Repair
Cardiac Myocytes
Ligation
Actins
Regeneration
Cause of Death
Heart Diseases
Coronary Vessels
Myocardium
Transcription Factors
Fibroblasts
Myocardial Infarction
Technology
Muscle
Peptides
Wounds and Injuries
Cells

Keywords

  • Cardiac repair
  • Cardiac reprogramming
  • Myocardial infarction
  • Thymosin β4

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Cardiac repair with thymosin β4 and cardiac reprogramming factors. / Srivastava, Deepak; Ieda, Masaki; Fu, Jidong; Qian, Li.

In: Annals of the New York Academy of Sciences, Vol. 1270, No. 1, 10.2012, p. 66-72.

Research output: Contribution to journalArticle

Srivastava, Deepak ; Ieda, Masaki ; Fu, Jidong ; Qian, Li. / Cardiac repair with thymosin β4 and cardiac reprogramming factors. In: Annals of the New York Academy of Sciences. 2012 ; Vol. 1270, No. 1. pp. 66-72.
@article{56248c91f0e14830a6b7d20ddd9c0cdd,
title = "Cardiac repair with thymosin β4 and cardiac reprogramming factors",
abstract = "Heart disease is a leading cause of death in newborns and in adults. We previously reported that the G-actin-sequestering peptide thymosin β4 promotes myocardial survival in hypoxia and promotes neoangiogenesis, resulting in cardiac repair after injury. More recently, we showed that reprogramming of cardiac fibroblasts to cardiomyocyte-like cells in vivo after coronary artery ligation using three cardiac transcription factors (Gata4/Mef2c/Tbx5) offers an alternative approach to regenerate heart muscle. We have combined the delivery of thymosin β4 and the cardiac reprogramming factors to further enhance the degree of cardiac repair and improvement in cardiac function after myocardial infarction. These findings suggest that thymosin β4 and cardiac reprogramming technology may synergistically limit damage to the heart and promote cardiac regeneration through the stimulation of endogenous cells within the heart.",
keywords = "Cardiac repair, Cardiac reprogramming, Myocardial infarction, Thymosin β4",
author = "Deepak Srivastava and Masaki Ieda and Jidong Fu and Li Qian",
year = "2012",
month = "10",
doi = "10.1111/j.1749-6632.2012.06696.x",
language = "English",
volume = "1270",
pages = "66--72",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Cardiac repair with thymosin β4 and cardiac reprogramming factors

AU - Srivastava, Deepak

AU - Ieda, Masaki

AU - Fu, Jidong

AU - Qian, Li

PY - 2012/10

Y1 - 2012/10

N2 - Heart disease is a leading cause of death in newborns and in adults. We previously reported that the G-actin-sequestering peptide thymosin β4 promotes myocardial survival in hypoxia and promotes neoangiogenesis, resulting in cardiac repair after injury. More recently, we showed that reprogramming of cardiac fibroblasts to cardiomyocyte-like cells in vivo after coronary artery ligation using three cardiac transcription factors (Gata4/Mef2c/Tbx5) offers an alternative approach to regenerate heart muscle. We have combined the delivery of thymosin β4 and the cardiac reprogramming factors to further enhance the degree of cardiac repair and improvement in cardiac function after myocardial infarction. These findings suggest that thymosin β4 and cardiac reprogramming technology may synergistically limit damage to the heart and promote cardiac regeneration through the stimulation of endogenous cells within the heart.

AB - Heart disease is a leading cause of death in newborns and in adults. We previously reported that the G-actin-sequestering peptide thymosin β4 promotes myocardial survival in hypoxia and promotes neoangiogenesis, resulting in cardiac repair after injury. More recently, we showed that reprogramming of cardiac fibroblasts to cardiomyocyte-like cells in vivo after coronary artery ligation using three cardiac transcription factors (Gata4/Mef2c/Tbx5) offers an alternative approach to regenerate heart muscle. We have combined the delivery of thymosin β4 and the cardiac reprogramming factors to further enhance the degree of cardiac repair and improvement in cardiac function after myocardial infarction. These findings suggest that thymosin β4 and cardiac reprogramming technology may synergistically limit damage to the heart and promote cardiac regeneration through the stimulation of endogenous cells within the heart.

KW - Cardiac repair

KW - Cardiac reprogramming

KW - Myocardial infarction

KW - Thymosin β4

UR - http://www.scopus.com/inward/record.url?scp=84867371272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867371272&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.2012.06696.x

DO - 10.1111/j.1749-6632.2012.06696.x

M3 - Article

C2 - 23050819

AN - SCOPUS:84867371272

VL - 1270

SP - 66

EP - 72

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -